To observe pain relief following neck block in patients undergoing middle ear surgeries

To evaluate analgesic efficacy of superficial cervical plexus block in patients undergoing modified radical mastoidectomy: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017712

Enrollment

Registered

2019-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group-I : 5ml of 0.5% ropivacaine in ultrasound guidance superficial cervical plexus block given at end of surgery Control Intervention1: Group -II : No block,only sterile dressing is

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 to 65 years of age group 2. American Society of Anaesthesiology(ASA)physical status I and II of both sex 3. Body mass index(BMI) 20 to 35kg/m2

Exclusion criteria

Exclusion criteria: 1.Patients having history of alcohol abuse 2.Patients having history of PONV, motion sickness 3.Patients receiving drugs for chronic pain management 4.Patients having allergy or contraindications to drugs used in present study 5.Patients having any history of migraine, seizure 6.Patients having any history of malignancy 7.Pregnancy and lactating mothers

Design outcomes

Primary

Measure	Time frame
Reduction in Visual analog score(VAS)Timepoint: Postoperative at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours.	—

Secondary

Measure	Time frame
1.Haemodynamics 2.Total rescue analgesia 3.Time to first rescue analgesia 4.Nausea/vomiting 5.Vertigo 6.Adverse effectsTimepoint: 1. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 2. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 3. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 4. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 5. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 6.at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours.	—

Measure

Time frame

1.Haemodynamics 2.Total rescue analgesia 3.Time to first rescue analgesia 4.Nausea/vomiting 5.Vertigo 6.Adverse effectsTimepoint: 1. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 2. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 3. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 4. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 5. at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours. 6.at 5, 10, 15 minutes , 1, 4, 8, 12, 18, 24 hours.

—

Countries

India

Contacts

Public ContactDr Vanita Ahuja

Government Medical College

deepikavijaya26@gmail.com9676276252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026